Patients with questions about specific travel situations, such as extended trips to very hot or cold climates, multi-leg journeys, or travel without access to reliable refrigeration, should consult their pharmacist in advance
A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy
ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, ASC39, an eloralintide-like potent and amylin-selective oral small molecule amylin receptor agonist, ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1 RA) and ASC39 (amylin RA), ASC30_48 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1 RA) and ASC48 (GIP RA), for chronic weight management
The cohort study from the University of Oxford (n 100,000) showed a 48% lower risk of dementia among semaglutide users compared to those treated with sitagliptin
We used a funnel plot to assess publication bias
NAD+ metabolism and the control of energy homeostasis - a balancing act between mitochondria and the nucleus
